John Rhodes, Global Managing Partner, Life Sciences, Deloitte & Touche LLP to Speak at KC’s Event on Revenue Recognition for Biotech Firms on 7/29/2009
The Knowledge Congress, the leading producer of regulatory focused webcast announced today that John Rhodes, Global Managing Partner, Life Sciences, Deloitte & Touche LLP, will speak at the Knowledge Congress’ upcoming webcast entitled: “Revenue Recognition for Biotech Firms Live Webcast.” This 2-hour event is scheduled on July 29, 2009, Wednesday at 3:00 PM – 5:00 PM ET.
New York, NY, June 19, 2009 --(PR.com)-- The Knowledge Congress, the leading producer of regulatory focused webcast announced today that John Rhodes, Global Managing Partner, Life Sciences, Deloitte & Touche LLP, will speak at the Knowledge Congress’ upcoming webcast entitled: “Revenue Recognition for Biotech Firms Live Webcast.” This 2-hour event is scheduled on July 29, 2009, Wednesday at 3:00 PM – 5:00 PM ET. (For further details of the event and an updated list of panelists, please visit: http://knowledgecongress.org/event_2009_Biotech.html)
Event Summary
Biotechnology companies face considerable challenges in applying accounting principles related to revenue recognition because they partner with larger companies through collaborative arrangements to pursue scientific innovation. Under these arrangements, the companies agree to share technology and research costs associated with bringing medical therapies to market and this gives them access to additional funding and commercialization networks. How the companies should recognize revenues under these arrangements is not entirely clear under current accounting guidance, and some companies have had to restate their financial results because of the lack of clarity. Moreover, some commentators have suggested that the current rules may not accurately reflect the underlying economics of the deals.
The Knowledge Congress is assembling a panel of accounting and biotechnology industry experts to help biotechnology company finance and legal advisers understand the revenue recognition principals as applied in this industry. Panel members will share their expertise in a Live two-hour Webcast.
About John Rhodes
John is the Global Managing Partner for the firm’s Life Sciences Industry Practice with 27 years of experience. In this role, he is responsible for the firm’s services to pharmaceutical, biotechnology and medical products companies and has worked with many large and small companies in all industry sectors. John has significant experience with pharmaceutical, biotechnology and medical products companies focusing on accounting and auditing, SEC reporting, business process and contracting issues, corporate compliance, strategic alliances, research and promotion collaborations, joint venture formations and mergers and acquisitions.
• Founder & Chair of the Annual Pharmaceutical Accounting & Reporting Congress, March 2005-March 2009
• Chair of First Annual Pharmaceutical Sarbanes Sustainability Congress, September 2005
• Editorial Board Member, Pharmaceutical Business Strategies Publication, Pharmaceutical Commerce
• Past Member, AICPA Expert Roundtable Pharmaceuticals and Biotechnology
About Deloitte & Touche LLP
“Deloitte” is the brand under which 165,000 dedicated professionals in independent firms throughout the world collaborate to provide audit, consulting, financial advisory, risk management, and tax services to selected clients.
For more information about John Rhodes, and Deloitte, please visit: www.deloitte.com
About The Knowledge Congress
The Knowledge Congress is an organization that produces webcast that examine regulatory changes across a variety of industries. “We bring together the world's leading authorities and industry participants through informative two-hour Live webcast to study the impact of changing regulations.”
To contact or to register for an event, please visit: www.knowledgecongress.org.
###
Event Summary
Biotechnology companies face considerable challenges in applying accounting principles related to revenue recognition because they partner with larger companies through collaborative arrangements to pursue scientific innovation. Under these arrangements, the companies agree to share technology and research costs associated with bringing medical therapies to market and this gives them access to additional funding and commercialization networks. How the companies should recognize revenues under these arrangements is not entirely clear under current accounting guidance, and some companies have had to restate their financial results because of the lack of clarity. Moreover, some commentators have suggested that the current rules may not accurately reflect the underlying economics of the deals.
The Knowledge Congress is assembling a panel of accounting and biotechnology industry experts to help biotechnology company finance and legal advisers understand the revenue recognition principals as applied in this industry. Panel members will share their expertise in a Live two-hour Webcast.
About John Rhodes
John is the Global Managing Partner for the firm’s Life Sciences Industry Practice with 27 years of experience. In this role, he is responsible for the firm’s services to pharmaceutical, biotechnology and medical products companies and has worked with many large and small companies in all industry sectors. John has significant experience with pharmaceutical, biotechnology and medical products companies focusing on accounting and auditing, SEC reporting, business process and contracting issues, corporate compliance, strategic alliances, research and promotion collaborations, joint venture formations and mergers and acquisitions.
• Founder & Chair of the Annual Pharmaceutical Accounting & Reporting Congress, March 2005-March 2009
• Chair of First Annual Pharmaceutical Sarbanes Sustainability Congress, September 2005
• Editorial Board Member, Pharmaceutical Business Strategies Publication, Pharmaceutical Commerce
• Past Member, AICPA Expert Roundtable Pharmaceuticals and Biotechnology
About Deloitte & Touche LLP
“Deloitte” is the brand under which 165,000 dedicated professionals in independent firms throughout the world collaborate to provide audit, consulting, financial advisory, risk management, and tax services to selected clients.
For more information about John Rhodes, and Deloitte, please visit: www.deloitte.com
About The Knowledge Congress
The Knowledge Congress is an organization that produces webcast that examine regulatory changes across a variety of industries. “We bring together the world's leading authorities and industry participants through informative two-hour Live webcast to study the impact of changing regulations.”
To contact or to register for an event, please visit: www.knowledgecongress.org.
###
Contact
The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
Thomas LaPointe, Jr., Executive Director
1.800.578.4370
www.knowledgecongress.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Thomas LaPointe, Jr., Executive Director
1.800.578.4370
www.knowledgecongress.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Contact
Categories